Bio-identical Hormone & Peptide Specialists

Table of Contents
Cardio Res-Q Assessment from $775

Advanced labs, the Cleveland Heart panel and Dr. Varano’s evaluation:

ApoB Levels Chart: What Counts as Normal, High and On Target for Your Risk

ApoB Levels Chart: What Counts as Normal, High and On Target for Your Risk

There is no single "normal" ApoB that fits everyone. The level worth aiming for depends on your overall risk of a heart attack or stroke: the higher that risk, the lower the ApoB your clinician is likely to want.

As reference points, US lipid specialists use 90, 70 and 60 mg/dL as decision levels for people at borderline-to-intermediate, high and very high risk. A result of 130 mg/dL or more is treated as a warning sign in its own right. The two charts below show where those numbers come from.

Key takeaways

  • ApoB decision levels get stricter as your overall risk goes up, so one cutoff cannot apply to everybody.
  • An average ApoB is not the same as a healthy one: the midpoint for untreated US adults is about 90 mg/dL.
  • A result of 130 mg/dL or higher puts you in roughly the top tenth of the population.
  • Words like "optimal" and "borderline" are not official ApoB categories, and labs flag results differently.

Chart 1: where your ApoB sits in the population

The first useful question is how your number compares with other adults. The best US data come from a national health survey of 12,696 adults who were not taking lipid-lowering medication.

PercentileApoB (mg/dL)Plain reading
10th61Lower than 9 in 10 adults
30th77Below average
50th90The middle of the population
70th104Above average
90th125Higher than 9 in 10 adults
95th137Top 5%

In that survey, the middle value for ApoB among untreated adults was 90 mg/dL.1

Keep one thing in mind when you read this chart. Heart disease is common, so sitting in the middle of the population is not the same as being at low risk. The percentile tells you where you stand. It does not tell you where you should be.

Chart 2: ApoB decision levels by risk

The second question is what level makes sense for someone with your risk. US guidelines set their numbers for LDL cholesterol first. In 2024 the National Lipid Association worked out the ApoB values that match them.

Your risk categoryLDL cholesterol levelMatching ApoB level
Borderline to intermediate100 mg/dL90 mg/dL
High70 mg/dL70 mg/dL
Very high55 mg/dL60 mg/dL

The National Lipid Association suggests ApoB thresholds of 90, 70 and 60 mg/dL for people at borderline-to-intermediate, high and very high risk.1

Read these as decision points, not as pass or fail marks. If your result is at or above the level for your category, it is a reason to talk about doing more. If it is below, your current approach is probably holding the particle count where it should be.

Your category comes from your whole picture: age, blood pressure, diabetes, smoking, kidney function and whether you already have heart disease. Our guide to the PREVENT risk calculator explains how the estimate is made. Very high risk generally means established cardiovascular disease plus further events or several high-risk conditions.

What counts as high

One number is flagged for everyone. An ApoB of 130 mg/dL sits at about the 90th percentile of untreated adults and is listed as a risk-enhancing factor in US cholesterol guidance.12 If your calculated risk falls in a gray zone, a result at this level can tip the discussion toward treatment.

Your lab may draw the line somewhere else. A European consensus statement advises laboratories to flag ApoB at 100 mg/dL or higher.3 So a result of 105 may be marked "high" on one report and unmarked on another. The flag depends on the lab. Your risk does not.

Why "optimal" and "borderline" are not official labels

You will see charts online that sort ApoB into tidy bands with names. No US guideline defines such bands. The relationship between ApoB and risk is a slope, not a staircase.

In a study of about 390,000 UK adults not taking lipid-lowering treatment, the risk of a first heart attack rose 27% for each standard-deviation step up in ApoB.4 There was no level at which risk suddenly switched on. That is why the charts above give decision points tied to risk instead of a universal "good" number.

Guidelines also stop short of asking everyone to hit an ApoB target. The 2026 ACC/AHA guideline does not recommend ApoB testing for everyone and advises using it selectively, where LDL cholesterol may not tell the full story.56 Our article on high ApoB with normal LDL covers that situation.

Before you compare numbers

  • Check the unit. Most US labs report mg/dL. Some report g/L. To convert, multiply g/L by 100, so 1.0 g/L equals 100 mg/dL.
  • Treated and untreated numbers differ. In a pooled analysis of 11 trials, LDL-lowering therapy cut ApoB by an average of 33% and LDL cholesterol by 42%.1 On treatment, ApoB can lag behind an LDL result that looks excellent.
  • A meal barely moves it. ApoB is not affected by whether you fasted.3 It is usually drawn with tests that do need fasting, so follow the instructions you are given.

For what ApoB is and how it differs from LDL cholesterol, see our ApoB test guide.

ApoB in a Cardio Res-Q assessment

ApoB is part of the lab panel in both Cardio Res-Q assessments: the Comprehensive Assessment ($775) and the Enhanced Assessment ($999), which adds a CIMT ultrasound and a coronary calcium score. Your result is read against your risk category, not against a single cutoff, alongside Lp(a), hs-CRP, insulin, glucose and A1c.

To see how the two options differ, read Comprehensive vs Enhanced Assessment. To book, go to the Cardio Res-Q program page.

Cardiovascular Risk Screener

Are You a Candidate for Cardio Res-Q?

Three quick questions about the risk factors we screen for. Your answers stay between you and the clinic.

Frequently asked questions

Is an ApoB of 90 mg/dL good?

It is average for an untreated US adult. Whether it is good for you depends on your risk. For someone at low risk it may need no action. For someone with established heart disease it is well above the level specialists suggest.

What ApoB level is considered high?

A result of 130 mg/dL or more is flagged as a risk-enhancing factor for anyone. Lower levels can still be too high for you if your overall risk is high, which is why the decision levels fall to 70 and 60 mg/dL in the higher risk categories.

My report shows ApoB in g/L. How do I read it?

Multiply by 100 to get mg/dL. A result of 0.85 g/L is 85 mg/dL. Then compare it with the charts above.

How often should ApoB be rechecked?

ApoB responds to changes in weight, diet and medication, so it is worth repeating after a change in your plan. The right interval depends on your situation, and your clinician will set it. See our guide on how often to repeat heart tests for the general picture.

Related reading

This article is for general education and is not medical advice. Decisions about testing and medication should be made with your clinician. If you have chest pain or other symptoms of a heart attack, call 911.

Optimize Your Health Today!

Cardio Res-Q starts with the $775 Comprehensive or $999 Enhanced Assessment, led by Dr. Varano.

age management doctor philadelphia
Send Us A Message
About Dr. Kenneth Varano, D.O.
age management doctor philadelphia

YoungerMeMD is a physician-led practice in Anti-Aging, Functional and Preventive Medicine, and your care is delivered by our whole clinical team. That team works under Medical Director Kenneth Varano, D.O., who brings over 30 years in clinical medicine and more than 20 years in age management and functional medicine — using science-backed, patient-focused strategies that restore balance, vitality, and health longevity.

About Barbara Dougherty
anti aging treatments

Barbara Dougherty, MSN, CRNP, is a Board-Certified Family Nurse Practitioner and Certified Menopause Practitioner (MSCP) specializing in optimizing hormones, and improving cardio-metabolic health. 

Read Our Reviews

“I’ve been seeing Dr. Varano for just over a year now, and I don’t think I’ve been this healthy and energetic since grade school.

Transform Your Health Today

Ready to take the first step toward renewed energy, balance, and longevity? New patients can register for an initial evaluation to begin their personalized anti-aging journey with YoungerMe MD. Live Younger. Better. Longer. — with YoungerMe MD.

References

  1. Soffer DE, et al. Role of apolipoprotein B in the clinical management of cardiovascular risk in adults: An Expert Clinical Consensus from the National Lipid Association. J Clin Lipidol 2024. PMID 39256087 · doi:10.1016/j.jacl.2024.08.013↩
  2. Grundy SM, et al. 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation 2019. PMID 30586774 · doi:10.1161/CIR.0000000000000625↩
  3. Nordestgaard BG, et al. Fasting is not routinely required for determination of a lipid profile: clinical and laboratory implications including flagging at desirable concentration cut-points-a joint consensus statement from the European Atherosclerosis Society and European Federation of Clinical Chemistry and Laboratory Medicine. Eur Heart J 2016. PMID 27122601 · doi:10.1093/eurheartj/ehw152↩
  4. Marston NA, et al. Association of Apolipoprotein B-Containing Lipoproteins and Risk of Myocardial Infarction in Individuals With and Without Atherosclerosis: Distinguishing Between Particle Concentration, Type, and Content. JAMA Cardiol 2022. PMID 34773460 · doi:10.1001/jamacardio.2021.5083↩
  5. Blumenthal RS, et al. 2026 ACC/AHA/AACVPR/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Dyslipidemia: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation 2026. PMID 41824552 · doi:10.1161/CIR.0000000000001423↩
  6. Sabouret P, et al. The 2026 ACC/AHA Dyslipidemia Guideline: A Critical and Transatlantic Perspective on Personalized Lipid Management. Life (Basel) 2026. PMID 42795336 · doi:10.3390/life16091470↩
Book a Discovery Call Peptide Consult
Close
Book a Discovery Call
Close
Peptide Consult







    Transform Your
    Health & Wellness

    Fill up the form below to get started

      Provocation agent administered prior to timed urine collection (<6hr). Reveals toxic metal burden that can block hormone and peptide response.

      Identifies gluten sensitivity, intestinal permeability (leaky gut), and wheat-related immune reactivity – distinct from standard celiac testing.

      DNA Based stool test detecting pathogens, bacterial imbalances, parasites, and digestive markers – a comprehensive gut microbiome assessment.

      Non-invasive carotid artery ultrasound measuring arterial wall thickness – a direct look at your cardiovascular age.

      Cardio Res-Q cardiac risk panel – inflammation markers and cardiovascular biomarkers beyond standard labs.

      Evaluates intracellular vitamin, mineral, and antioxidant status – foundational to optimizing cellular health and peptide efficacy.

      Full Sex hormone, thyroid and adrenal picture. Identifies imbalances that affect energy, recovery, cognition, and peptide response.

      Advanced testing for immune reactions to wheat, gluten, and intestinal permeability.

      What It Evaluates

      Heavy metals like mercury, lead, cadmium, arsenic, and aluminum can cause:

      Conditions We Identify